On May 6, 2023, during the 7th Future Healthcare 100 Summit, VBdata released the “2023 Future Healthcare 100 List.” HTDK, with its diversified value-added commercial services and innovative expansion in the medical device market, won the “2023 Future Healthcare 100 Award – Innovative Company of the Year.”

Overview of the Future Healthcare 100 List

Established in 2015, the Future Healthcare 100 List is China’s first innovation-focused healthcare ranking for non-listed companies, launched by VB100, VBdata, and Eggshell Research Institute. It aims to identify China’s leading innovators in the healthcare sector, discover the core forces of the future medical industry, and promote innovation in the health industry. Over seven years, the selection system has expanded to include enterprises, investment institutions, and industrial parks, evolving into a global innovation healthcare evaluation ecosystem, extending into innovative products and technologies.

Industry Recognition and Influence

The “Future Healthcare 100 Series Lists and Awards” have gained significant support and recognition from numerous investment institutions and companies, becoming a leading indicator for investment in the healthcare sector. It guides the development and investment trends in China’s healthcare innovation field, providing valuable references for subsequent financing of innovative enterprises.

HTDK has established itself as a “hidden champion” in the medical device commercialization platform by expanding its service chain in the vertical track. It offers diversified value-added services beyond traditional distribution, warehousing, and logistics, transitioning from horizontal expansion to deep vertical integration, covering the entire service chain.

Over the past decade, HTDK’s long-term, in-depth cooperation with global brands is attributed to its end-to-end service platform. Unlike companies that only provide direct sales and distribution, HTDK’s comprehensive services include product registration, import/export, warehousing and distribution, channel management, inventory management, and after-sales management. This one-stop service facilitates rapid growth for global brands in China, offering high-value-added services and solutions tailored to their industry and product characteristics and various development stages.

In 2022, HTDK expanded its second growth pole by partnering with SOFWAVE MEDICAL LTD, a market leader in the global ultrasound anti-aging field from Israel. HTDK provided end-to-end professional commercial solutions, aiding in the product’s registration with China’s National Medical Products Administration and accelerating its full commercialization in the Chinese market, including product promotion, distribution, and sales.